- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05309720
Dermal Substitution in Pediatric Burns (GlyPeB)
Dermal Substitution in Paediatric Burns: A Prospective Case Series
The standard treatment of deep dermal to full thickness burns is surgical removal of the burn followed by skin transplantation. Dermal substitutes are increasingly used in the treatment of deep burns to replace lost dermis. Preservation of the collagen and elastin in the acellular human dermal substitute Glyaderm provides a more elastic scar. It is unknown what the effect of Glyaderm on scar quality is in a solely paediatric population.
The objective of this case series is to investigate scar maturation and scar quality when applying Glyaderm in deep dermal to full thickness burns in a pediatric population aged ≤15 years old.
Study Overview
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Milly van de Warenburg, MD
- Phone Number: 0031 24 361 1111
- Email: milly.vandewarenburg@radboudumc.nl
Study Locations
-
-
-
Nijmegen, Netherlands
- Recruiting
- Radboudumc
-
Contact:
- Elleke Munk, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age ≤15 years old
- Burn wounds requiring skin grafting
Written informed consent provided by
- The participant's parent(s)/guardian (<12 years of age)
- The participant's parent(s)/guardian and the participant itself (12-15 years old)
Exclusion Criteria:
- Burn wound of ≤30 cm2
- Infected burn wounds: clinical symptoms in combination with positive wound swabs
- Patients/parents with insufficient knowledge of the Dutch or English language, since they would not be able to complete the POSAS questionnaire.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Glyaderm
|
All included patients will undergo full thickness removal of the burned skin or adequate debridement of all necrotic tissue.
Next, the dermal substitute Glyaderm followed by a split thickness skin graft will be transplanted on the wound.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Scar quality (clinician)
Time Frame: 12 months
|
Scar quality measured using the Patient and Observer Scar Assessment Scale (POSAS) Observer Scale, which rates the scar from 1 (=like normal skin) to 10 (=worst scar imaginable).
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical assessment of the graft take
Time Frame: 5-7 days after STSG application
|
Take of the split thickness skin graft (STSG) in percentages.
The take is defined as STSG that appears vital and is adherent to the wound bed.
|
5-7 days after STSG application
|
|
Wound epithelialization
Time Frame: 5-7 days after STSG application
|
Wound epithelialization is the percentage of the graft with a vital skin graft and healed graft interstices.
|
5-7 days after STSG application
|
|
Wound healing time
Time Frame: determined in the first several days to weeks after STSG application
|
>95% epithelialization of the wound area is considered as healed
|
determined in the first several days to weeks after STSG application
|
|
Donor site healing time
Time Frame: determined in the first several days to weeks after STSG application
|
>95% epithelialisation of the donor site wound surface area is considered as healed
|
determined in the first several days to weeks after STSG application
|
|
Scar surface area
Time Frame: day of surgery (day 0) and 3, 6 and 12 months post-surgery
|
The scar surface area is calculated using the surgery wound as reference area
|
day of surgery (day 0) and 3, 6 and 12 months post-surgery
|
|
Scar quality (participant)
Time Frame: 3, 6 and 12 months post-surgery
|
Scar quality measured using the Patient and Observer Scar Assessment Scale (POSAS) Patient Scale, rating the scar from 1 (=like normal skin) to 10 (=worst scar imaginable).
|
3, 6 and 12 months post-surgery
|
|
Occurrence of scar contractures
Time Frame: Up to 12 months post-surgery
|
Scar contractures often occur in children with deep dermal and full thickness burn wounds.
|
Up to 12 months post-surgery
|
|
Occurrence of scar hypertrophy
Time Frame: Up to 12 months post-surgery
|
Scar hypertrophy often occurs in children with deep dermal and full thickness burn wounds.
|
Up to 12 months post-surgery
|
|
Range of motion of affected joints
Time Frame: 3, 6 and 12 months post-surgery
|
When joints are affected due to the burn wound, the range of motion of the affected joint(s) will be monitored during follow-up.
|
3, 6 and 12 months post-surgery
|
Collaborators and Investigators
Investigators
- Principal Investigator: Marielle Vehmeijer-Heeman, MD, PhD, Radboud University Medical Center
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022-13625
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Burn Scar
-
Riphah International UniversityRecruiting
-
Medstar Health Research InstituteActive, not recruitingBurn Scar | ScarUnited States
-
Medstar Health Research InstituteActive, not recruitingBurn Scar | Scar | Skin Graft ScarUnited States
-
Bispebjerg HospitalUnknownBurn Scar PatientsDenmark
-
University of PittsburghUnited States Department of DefenseTerminatedBurn Scar | Restrictive Scar Contracture | Restrictive Hypertrophic Scar | Burn Scar ContracturesUnited States
-
Centre hospitalier de l'Université de Montréal...Completed
-
Cairo UniversityCompletedBurns | Hypertrophic Scar | Burn Scar (Post-burn)Egypt
-
MTI UniversityCompleted
-
University Hospital, LinkoepingCompletedBurn Scar | Burns | Burn Second DegreeSweden
-
Kaiyang Lv, MD-PhDZimmer Medical Devices (Shanghai) Co., Ltd.RecruitingBurn Scar | Cryotherapy Effect | Scar; Previous Cesarean SectionChina
Clinical Trials on Glyaderm
-
University Hospital, GhentResearch Foundation FlandersCompletedBurns | Necrotizing Fascitis | Full Thickness BurnBelgium
-
Euro Tissue BankDutch Burns FoundationTerminatedFull-thickness Skin Loss Due to Burn, Unspecified SiteSpain, Netherlands, Belgium, Greece
-
University Hospital, GhentDutch Burnwound Foundation, NetherlandCompletedFull Thickness Skin DefectsBelgium